Strategic Global Advisors, LLC Exelixis, Inc. Transaction History
Strategic Global Advisors, LLC
- $500 Million
- Q1 2025
A detailed history of Strategic Global Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 94,011 shares of EXEL stock, worth $4.08 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
94,011
Previous 96,831
2.91%
Holding current value
$4.08 Million
Previous $3.22 Million
7.63%
% of portfolio
0.69%
Previous 0.6%
Shares
5 transactions
Others Institutions Holding EXEL
# of Institutions
613Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.45 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.24 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$977 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$643 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$511 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...